[HTML][HTML] On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

EI Vrettos, G Mező, AG Tzakos - Beilstein journal of organic …, 2018 - beilstein-journals.org
Cancer is the second leading cause of death affecting nearly one in two people, and the
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …

[HTML][HTML] Natural peptides for immunological regulation in cancer therapy: mechanism, facts and perspectives

Y Zhang, C Liu, C Wu, L Song - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cancer incidence and mortality rates are increasing annually. Treatment with surgery,
chemotherapy and radiation therapy (RT) is unsatisfactory because many patients have …

[HTML][HTML] 3D approaches to model the tumor microenvironment of pancreatic cancer

E Tomás-Bort, M Kieler, S Sharma, JB Candido… - Theranostics, 2020 - ncbi.nlm.nih.gov
In tumor engineering, 3D approaches are used to model components of the tumor
microenvironment and to test new treatments. Pancreatic cancers are a cancer of substantial …

Pre-clinical models of metastasis in pancreatic cancer

M Miquel, S Zhang, C Pilarsky - Frontiers in cell and developmental …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a hostile solid malignancy coupled with an
extremely high mortality rate. Metastatic disease is already found in most patients at the time …

The interplay between neutrophils and microbiota in cancer

CK Smith, G Trinchieri - Journal of Leukocyte Biology, 2018 - academic.oup.com
The role of the microbiota in many diseases including cancer has gained increasing
attention. Paired with this is our expanding appreciation for the heterogeneity of the …

Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for …

JI Griffin, X Chen, L Duan, Q Mu, RJY Ho - Plos one, 2024 - journals.plos.org
Preclinical models of cancer are vital for assessing and predicting efficacies and toxicities of
novel treatments prior to testing in human subjects. Current pancreatic tumor models exhibit …

Identification and validation of a hypoxia-immune related prognostic signature for pancreatic cancer

X Qinhong, M Fandi, W Yong, L Zhengyang, L Xuqi - 2022 - researchsquare.com
Pancreatic cancer remains a lethal disease with poor prognosis. Immune and hypoxia are
critical characteristics of tumor microenvironment, and are closely associated with cancer …

3D approaches to model the tumour microenvironment of pancreatic cancer

D Loessner, E Tomás-Bort, M Kieler, S Sharma… - Theranostics, 2020 - qmro.qmul.ac.uk
In tumor engineering, 3D approaches are used to model components of the tumor
microenvironment and to test new treatments. Pancreatic cancers are a cancer of substantial …